 Home > Biochemistry News > Biotechnology News > Enpagliflozin is recognized by the FDA as a breakthrough therapy for the treatment of heart failure with preserved ejection fraction

Enpagliflozin is recognized by the FDA as a breakthrough therapy for the treatment of heart failure with preserved ejection fraction

 Last Update: 2021-10-02
 Source: Internet
 Author: User

Tags

adult wipes

levothyroxine medicine

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Boehringer Ingelheim (Boehringer Ingelheim) and Eli Lilly and Company (Eli Lilly and Company) today announced that the US FDA has granted Empagliflozin (English trade name Jardiance) breakthrough therapy designation for the treatment of heart failure with preserved ejection fraction (HFpEF) Adult patients

The decision is based on the results of the landmark phase 3 clinical trial EMPEROR-Preserved.

Heart failure is a progressive, debilitating and potentially fatal disease that occurs when the heart cannot provide enough circulation to meet the body's demand for oxygenated blood

Empagliflozin is a highly selective sodium-glucose cotransporter 2 (SGLT2) inhibitor that is taken orally once a day.

Reference materials:

[1] FDA grants Jardiance® Breakthrough Therapy designation for heart failure with preserved ejection fraction.

(The original text has been deleted)

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.